Locoregional recurrence and metastasis in the long-term follow-up of postmastectomy breast cancer patients with T1-T2 tumours and one to three positive lymph nodes

Clinical and Translational Oncology

Volumn 6, Issue 6, 2004, Pages 341-346

  Madrona, Antonio Piñero ^a   Ramos, Juan Salinas ^a   Moreno, Julián Illana ^a   Pérez, Joaquín Sola ^a   Jordana, Manuel Canteras ^b   De Las Heras González, Manuel ^a   Paricio, Pascual Parrilla ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Breast cancer; Follow up; Locoregional recurrence; Metastases

Indexed keywords

EID: 33847145640     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02710063     Document Type: Article

References (31)

1. Styblo TM, Wood WC. Traditional prognostic factors for breast cancer. In: Bland KI, Copeland EM III, editors. The breast. Comprehensive management of benign and malignant diseases. Vol 1. 2nd ed. Philadelphia, Pennsylvania: WB Saunders Company, 1998;p. 425.
2. Veronesi U, Banfi A, Del Vecchio M, et al. Comparison of Haldsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: Long term results. Eur J Cancer Clin Oncol 1986;22: 1085-9.
3. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993; 328:158791.
4. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe meted in patients with small cancer of the breast. Long-term results of three randomised trials on 1973 patients. Eur J Cancer 1995;31:1574-9.
5. Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncology Biol Phys 1999;44(5):989-900.
6. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539-69.
7. Arriagada R, Rutqvist LR, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995;13:2869-78.
8. Fowble B. Postmastectomy radiotherapy: then and now. Oncology (Huntgtn) 1997;11:213-39.
9. Kuske RR. Adjuvant irradiation after mastectomy in women with one to three positiva axillary nodes: then no; now yes. Semin Radiat Oncol 1999;9:254-8.
10. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17(6):1689-700.
11. Rosenman J, Bernard S, Kober C, Leland W, Varia M, Newsome J. Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (19701982). Cancer 1986;57:1421-5.
12. Sykes HF, Sim DA, Wong CJ, Cassady JR, Salmon SE. Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy. Evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1989;16:641-7.
13. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC. Identification of a subgroup of patients with breast cancer and positive nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988;6:1107-17.
14. Pisansky TM, Ingle JN, Schaid DJ, et al. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary node-positive breast cancer. Cancer 1993;72:1247-60.
15. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on regional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001;50:735-42.
16. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
17. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;37:956-62.
18. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8.
19. Jager JJ, Volovics L, Schouten LJ, et al. Loco-regional recurrences after mastectomy in breast cancer: Prognostic factors and implications for postoperative irradiation. Radiother Oncol 1999;50:267-75.
20. Cheng JC, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2002;52:980-8.
21. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 1994;12: 2229-34.
22. Freedman GM, Fowble BL, Hanlon AL, et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 1998;41:599-605.
23. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications and postoperative irradiation. J Clin Oncol 2000;18:2817-27.
24. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastasis for treatment and prognosis of breast cancer. Cancer 1993;72:778-82.
25. Fisher BJ, Perera FE, Cooke AL, et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: An indication for radiotherapy? Int J Radiat Oncol Biol Phys 1997;38:551-9.
26. Kuske RR, Sánchez M, Farr GH. Extracapsular axillary nodal extension (ECE) in breast cancer: Patterns of recurrence, arm edema, and survival after mastectomy with and without irradiation [abstract]. Proceedings of the 41st Annual ASTRO Meeting. Int J Radiat Oncol Biol Phys 1999;45(Suppl):157.
27. Morrison JM, Howell A, Kelly KA, et al. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: Results after a median follow-up of 7 years: I. Patients with involved lymph nodes. Br J Cancer 1989;60:911-8.
28. Castiglione M, Gelber RD, Goldhirsch A. Adjuvant systemic therapy for breast cancer in the elderly: Competing causes of mortality. International Breast Cancer Study Group. J Clin Oncol 1990;8:519-26.
29. Richards MA, O'Reilly SM, Howell A, et al. Adjuvant cyclophosphamide, methotrexate, and fluoruracil in patients with axillary node-positive breast cancer: An update of the Guy's Manchester trial. J Clin Oncol 1990;8: 2032-9.
30. Bang SM, Heo DS, Lee KH, et al. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluoruracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma. Cancer 2000;89:2521-6.
31. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development conference statement: adjuvant therapy for breast cancer. J Natl Cancer Inst 2001;93:979-89.